Published in J Cereb Blood Flow Metab on December 19, 2012
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol (2013) 6.18
Outcome markers for clinical trials in cerebral amyloid angiopathy. Lancet Neurol (2014) 2.39
Cardiovascular risk factors and future risk of Alzheimer's disease. BMC Med (2014) 1.00
Post-mortem assessment in vascular dementia: advances and aspirations. BMC Med (2016) 0.98
A Eu(II) -Containing Cryptate as a Redox Sensor in Magnetic Resonance Imaging of Living Tissue. Angew Chem Int Ed Engl (2015) 0.93
Robust and fragile aspects of cortical blood flow in relation to the underlying angioarchitecture. Microcirculation (2015) 0.91
New therapeutic approaches for Alzheimer's disease and cerebral amyloid angiopathy. Front Aging Neurosci (2014) 0.89
Ischemic brain injury in cerebral amyloid angiopathy. J Cereb Blood Flow Metab (2016) 0.89
Microinfarct disruption of white matter structure: a longitudinal diffusion tensor analysis. Neurology (2014) 0.89
Clinical and imaging features of mixed Alzheimer and vascular pathologies. Alzheimers Res Ther (2015) 0.87
Evolving Concept of Small Vessel Disease through Advanced Brain Imaging. J Stroke (2015) 0.87
Hypertension and Its Role in Cognitive Function: Current Evidence and Challenges for the Future. Am J Hypertens (2015) 0.86
The spectrum of MR detectable cortical microinfarcts: a classification study with 7-tesla postmortem MRI and histopathology. J Cereb Blood Flow Metab (2015) 0.84
Characterising the grey matter correlates of leukoaraiosis in cerebral small vessel disease. Neuroimage Clin (2015) 0.83
Review of 'the potential role of arterial stiffness in the pathogenesis of Alzheimer's disease'. Neurodegener Dis Manag (2015) 0.83
Molecular disorganization of axons adjacent to human lacunar infarcts. Brain (2015) 0.83
Quantitative T2, T2*, and T2' MR imaging in patients with ischemic leukoaraiosis might detect microstructural changes and cortical hypoxia. Neuroradiology (2015) 0.80
Spectroscopic Characterization of the 3+ and 2+ Oxidation States of Europium in a Macrocyclic Tetraglycinate Complex. Inorg Chem (2016) 0.79
Cortical microinfarcts on 7T MRI in patients with spontaneous intracerebral hemorrhage. J Cereb Blood Flow Metab (2014) 0.79
Microvascular basis for growth of small infarcts following occlusion of single penetrating arterioles in mouse cortex. J Cereb Blood Flow Metab (2015) 0.78
Estimating Total Cerebral Microinfarct Burden From Diffusion-Weighted Imaging. Stroke (2015) 0.78
First translational 'Think Tank' on cerebrovascular disease, cognitive impairment and dementia. J Transl Med (2016) 0.77
Hippocampal T2 hyperintensities on 7 Tesla MRI. Neuroimage Clin (2013) 0.77
7.0 T MRI detection of cerebral microinfarcts in patients with a symptomatic high-grade carotid artery stenosis. J Cereb Blood Flow Metab (2014) 0.77
Relations between location and type of intracranial atherosclerosis and parenchymal damage. J Cereb Blood Flow Metab (2015) 0.77
Neuroimaging in vascular cognitive impairment: a state-of-the-art review. BMC Med (2016) 0.76
Role of Vascular Disease in Alzheimer-Like Progressive Cognitive Impairment. Stroke (2015) 0.76
New insights into vascular pathology by ultrahigh-field magnetic resonance imaging. J Cereb Blood Flow Metab (2012) 0.75
Perspectives of Ultra-High-Field MRI in Neuroradiology. Clin Neuroradiol (2015) 0.75
Imaging markers of cerebrovascular pathologies: Pathophysiology, clinical presentation, and risk factors. Alzheimers Dement (Amst) (2016) 0.75
Structural MR Imaging in the Diagnosis of Alzheimer's Disease and Other Neurodegenerative Dementia: Current Imaging Approach and Future Perspectives. Korean J Radiol (2016) 0.75
In Vitro Longitudinal Relaxivity Profile of Gd(ABE-DTTA), an Investigational Magnetic Resonance Imaging Contrast Agent. PLoS One (2016) 0.75
Association Between Subclinical Cardiac Biomarkers and Clinically Manifest Cardiac Diseases With Cortical Cerebral Microinfarcts. JAMA Neurol (2017) 0.75
Detection superiority of 7 T MRI protocol in patients with epilepsy and suspected focal cortical dysplasia. Acta Neurol Belg (2016) 0.75
Comparative Analysis of Cortical Microinfarcts and Microbleeds using 3.0-Tesla Postmortem Magnetic Resonance Images and Histopathology. J Alzheimers Dis (2017) 0.75
Carotid Atherosclerosis and Cognitive Impairment in Nonstroke Patients. Chin Med J (Engl) (2017) 0.75
Risk Factors and Clinical Manifestations of Juxtacortical Small Lesions: A Neuroimaging Study. Front Neurol (2017) 0.75
Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (1991) 49.03
Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging (2002) 22.40
The mini-mental state examination: a comprehensive review. J Am Geriatr Soc (1992) 15.32
Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology (2007) 9.27
A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke (2001) 5.81
Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol (2010) 5.76
Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol (2009) 4.60
Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants. Ann N Y Acad Sci (2002) 3.11
Staging and natural history of cerebrovascular pathology in dementia. Neurology (2012) 2.61
Microinfarct pathology, dementia, and cognitive systems. Stroke (2011) 2.61
Cerebral microinfarcts: the invisible lesions. Lancet Neurol (2012) 2.31
Fast spin echo sequences with very long echo trains: design of variable refocusing flip angle schedules and generation of clinical T2 contrast. Magn Reson Med (2006) 2.22
Comparison of 7.0-T T₂*-magnetic resonance imaging of cerebral bleeds in post-mortem brain sections of Alzheimer patients with their neuropathological correlates. Cerebrovasc Dis (2011) 2.05
Heterogeneity of white matter hyperintensities in Alzheimer's disease: post-mortem quantitative MRI and neuropathology. Brain (2008) 1.84
Ecology of the aging human brain. Arch Neurol (2011) 1.78
Cerebral hypoperfusion generates cortical watershed microinfarcts in Alzheimer disease. Stroke (2002) 1.66
Postmortem MR imaging of formalin-fixed human brain. Neuroimage (2004) 1.65
Microinfarcts, brain atrophy, and cognitive function: the Honolulu Asia Aging Study Autopsy Study. Ann Neurol (2011) 1.65
Towards defining the neuropathological substrates of vascular dementia. J Neurol Sci (2004) 1.63
Subfields of the hippocampal formation at 7 T MRI: in vivo volumetric assessment. Neuroimage (2012) 1.49
Cerebral microinfarcts: a systematic review of neuropathological studies. J Cereb Blood Flow Metab (2012) 1.47
High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis. Brain (2010) 1.42
Cortical microinfarcts and demyelination affect cognition in cases at high risk for dementia. Neurology (2007) 1.31
Cerebrovascular disease and mechanisms of cognitive impairment: evidence from clinicopathological studies in humans. Stroke (2012) 1.21
High-resolution magnetization-prepared 3D-FLAIR imaging at 7.0 Tesla. Magn Reson Med (2010) 1.18
Ultrahigh-field MRI in human ischemic stroke--a 7 tesla study. PLoS One (2012) 0.97
The neuropathology of vascular disease in the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Curr Alzheimer Res (2012) 0.91
MRI artifacts in human brain tissue after prolonged formalin storage. Magn Reson Med (2011) 0.89
In vivo detection of cortical microinfarcts on ultrahigh-field MRI. J Neuroimaging (2012) 0.88
The effects of type 1 diabetes on cognitive performance: a meta-analysis. Diabetes Care (2005) 3.36
Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes. Diabetes (2006) 2.77
Cognitive outcomes 7.5 years after angioplasty compared with off-pump coronary bypass surgery. Ann Thorac Surg (2013) 2.64
Brain imaging in patients with diabetes: a systematic review. Diabetes Care (2006) 2.39
Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology. Eur Radiol (2008) 2.05
Interventricular mechanical asynchrony in pulmonary arterial hypertension: left-to-right delay in peak shortening is related to right ventricular overload and left ventricular underfilling. J Am Coll Cardiol (2008) 1.97
Diabetes and other vascular risk factors for dementia: which factor matters most? A systematic review. Eur J Pharmacol (2008) 1.91
Can arterial spin labeling detect white matter perfusion signal? Magn Reson Med (2009) 1.84
Glutamate in schizophrenia: a focused review and meta-analysis of ¹H-MRS studies. Schizophr Bull (2011) 1.78
Disruption of cerebral networks and cognitive impairment in Alzheimer disease. Neurology (2013) 1.76
Cognitive dysfunction in patients with type 2 diabetes. Diabetes Metab Res Rev (2010) 1.74
Perfusion imaging using arterial spin labeling. Top Magn Reson Imaging (2004) 1.65
Diabetes, hyperglycaemia, and acute ischaemic stroke. Lancet Neurol (2012) 1.63
Progression of cerebral atrophy and white matter hyperintensities in patients with type 2 diabetes. Diabetes Care (2010) 1.61
Type 2 diabetes mellitus, hypertension, dyslipidemia and obesity: A systematic comparison of their impact on cognition. Biochim Biophys Acta (2008) 1.60
MicroRNA-146a: a key regulator of astrocyte-mediated inflammatory response. PLoS One (2012) 1.59
Myocardial strain and torsion quantified by cardiovascular magnetic resonance tissue tagging: studies in normal and impaired left ventricular function. J Am Coll Cardiol (2006) 1.59
Hyperglycemia in acute ischemic stroke: pathophysiology and clinical management. Nat Rev Neurol (2010) 1.55
Clinical proton MR spectroscopy in central nervous system disorders. Radiology (2014) 1.53
Correction of phase offset errors in main pulmonary artery flow quantification. J Magn Reson Imaging (2005) 1.51
Cerebral microinfarcts: a systematic review of neuropathological studies. J Cereb Blood Flow Metab (2012) 1.47
No evidence of microbleeds in ALS patients at 7 Tesla MRI. Amyotroph Lateral Scler (2010) 1.46
Comparison and reproducibility of ADC measurements in breathhold, respiratory triggered, and free-breathing diffusion-weighted MR imaging of the liver. J Magn Reson Imaging (2008) 1.44
Intracranial vessel wall imaging at 7.0-T MRI. Stroke (2011) 1.44
Cognitive performance, psychological well-being, and brain magnetic resonance imaging in older patients with type 1 diabetes. Diabetes (2006) 1.44
Intratumoral administration of holmium-166 acetylacetonate microspheres: antitumor efficacy and feasibility of multimodality imaging in renal cancer. PLoS One (2013) 1.42
Cerebral cortical thickness in patients with type 2 diabetes. J Neurol Sci (2010) 1.34
Diabetes increases atrophy and vascular lesions on brain MRI in patients with symptomatic arterial disease. Stroke (2008) 1.33
Intra- and multicenter reproducibility of pulsed, continuous and pseudo-continuous arterial spin labeling methods for measuring cerebral perfusion. J Cereb Blood Flow Metab (2011) 1.31
Disruption of the cerebral white matter network is related to slowing of information processing speed in patients with type 2 diabetes. Diabetes (2013) 1.29
Extended harmonic phase tracking of myocardial motion: improved coverage of myocardium and its effect on strain results. J Magn Reson Imaging (2006) 1.29
Diffusion-weighted MR neurography of the brachial plexus: feasibility study. Radiology (2008) 1.27
Brain perfusion territory imaging: methods and clinical applications of selective arterial spin-labeling MR imaging. Radiology (2008) 1.27
Clinical applications of 7 T MRI in the brain. Eur J Radiol (2011) 1.27
Whole-body diffusion-weighted magnetic resonance imaging. Eur J Radiol (2009) 1.25
Novel MRI approaches for assessing cerebral hemodynamics in ischemic cerebrovascular disease. Stroke (2012) 1.24
Microstructural white matter abnormalities and cognitive functioning in type 2 diabetes: a diffusion tensor imaging study. Diabetes Care (2012) 1.22
Arterial spin labeling perfusion MRI at multiple delay times: a correlative study with H(2)(15)O positron emission tomography in patients with symptomatic carotid artery occlusion. J Cereb Blood Flow Metab (2009) 1.19
High-resolution magnetization-prepared 3D-FLAIR imaging at 7.0 Tesla. Magn Reson Med (2010) 1.18
Structural MRI reveals cortical thinning in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry (2011) 1.18
Cognition in the early stage of type 2 diabetes. Diabetes Care (2009) 1.17
Evaluation of the innate and adaptive immunity in type I and type II focal cortical dysplasias. Epilepsia (2010) 1.17
Activation of Toll-like receptor, RAGE and HMGB1 signalling in malformations of cortical development. Brain (2011) 1.16
In vivo flow territory mapping of major brain feeding arteries. Neuroimage (2005) 1.15
Quantitative diffusion weighted imaging for differentiation of benign and malignant breast lesions: the influence of the choice of b-values. J Magn Reson Imaging (2010) 1.15
Symptomatic carotid artery occlusion: flow territories of major brain-feeding arteries. Radiology (2007) 1.15
Influence of cardiac motion on diffusion-weighted magnetic resonance imaging of the liver. MAGMA (2009) 1.15
Whole-brain arterial spin labeling perfusion MRI in patients with acute stroke. Stroke (2012) 1.14
Accelerated cognitive decline in patients with type 2 diabetes: MRI correlates and risk factors. Diabetes Metab Res Rev (2011) 1.14
Perforating arteries originating from the posterior communicating artery: a 7.0-Tesla MRI study. Eur Radiol (2009) 1.12
A detailed profile of cognitive dysfunction and its relation to psychological distress in patients with type 2 diabetes mellitus. J Int Neuropsychol Soc (2007) 1.12
Localization of breast cancer resistance protein (BCRP) in microvessel endothelium of human control and epileptic brain. Epilepsia (2005) 1.12
B1(+) phase mapping at 7 T and its application for in vivo electrical conductivity mapping. Magn Reson Med (2011) 1.12
Gene expression analysis of tuberous sclerosis complex cortical tubers reveals increased expression of adhesion and inflammatory factors. Brain Pathol (2009) 1.12
White matter lesions and brain atrophy: more than shared risk factors? A systematic review. Cerebrovasc Dis (2009) 1.11
ADC measurements of lymph nodes: inter- and intra-observer reproducibility study and an overview of the literature. Eur J Radiol (2009) 1.11
Fluid attenuated inversion recovery (FLAIR) MRI at 7.0 Tesla: comparison with 1.5 and 3.0 Tesla. Eur Radiol (2009) 1.09
High prevalence of cerebral microbleeds at 7Tesla MRI in patients with early Alzheimer's disease. J Alzheimers Dis (2012) 1.09
FUS mutations in familial amyotrophic lateral sclerosis in the Netherlands. Arch Neurol (2010) 1.08
MR angiography of the cerebral perforating arteries with magnetization prepared anatomical reference at 7 T: comparison with time-of-flight. J Magn Reson Imaging (2008) 1.08
31P MRSI and 1H MRS at 7 T: initial results in human breast cancer. NMR Biomed (2011) 1.07
Hemodynamic changes after visual stimulation and breath holding provide evidence for an uncoupling of cerebral blood flow and volume from oxygen metabolism. J Cereb Blood Flow Metab (2008) 1.06
Complementary roles of whole-body diffusion-weighted MRI and 18F-FDG PET: the state of the art and potential applications. J Nucl Med (2010) 1.06
A comparison of MR based segmentation methods for measuring brain atrophy progression. Neuroimage (2010) 1.05
Cortical depth-dependent temporal dynamics of the BOLD response in the human brain. J Cereb Blood Flow Metab (2011) 1.05
Multiple acquisitions with global inversion cycling (MAGIC): a multislice technique for vascular-space-occupancy dependent fMRI. Magn Reson Med (2004) 1.05
Signal to noise ratio and uncertainty in diffusion tensor imaging at 1.5, 3.0, and 7.0 Tesla. J Magn Reson Imaging (2011) 1.05
Cerebral dysfunction in type 1 diabetes: effects of insulin, vascular risk factors and blood-glucose levels. Eur J Pharmacol (2004) 1.04
ALS-associated mutations in FUS disrupt the axonal distribution and function of SMN. Hum Mol Genet (2013) 1.04
Associations between retinal microvascular changes and dementia, cognitive functioning, and brain imaging abnormalities: a systematic review. J Cereb Blood Flow Metab (2013) 1.03
Symptomatic carotid artery stenosis: impairment of cerebral autoregulation measured at the brain tissue level with arterial spin-labeling MR imaging. Radiology (2010) 1.03
Heart failure and cognitive function in the general population: the Hoorn Study. Eur J Heart Fail (2011) 1.02
Mechanical dyssynchrony or myocardial shortening as MRI predictor of response to biventricular pacing? J Magn Reson Imaging (2007) 1.01
Microvascular determinants of cognitive decline and brain volume change in elderly patients with type 2 diabetes. Dement Geriatr Cogn Disord (2010) 1.01
Electrical properties tomography in the human brain at 1.5, 3, and 7T: a comparison study. Magn Reson Med (2013) 1.00
Diffusion-weighted MR neurography of the sacral plexus with unidirectional motion probing gradients. Eur Radiol (2009) 1.00
Clinicopathological and immunohistochemical findings in an autopsy case of tuberous sclerosis complex. Neuropathology (2008) 0.99
Cognitive functioning in elderly persons with type 2 diabetes and metabolic syndrome: the Hoorn study. Dement Geriatr Cogn Disord (2008) 0.99
Structural brain imaging in diabetes: a methodological perspective. Eur J Pharmacol (2008) 0.99
Fast high resolution whole brain T2* weighted imaging using echo planar imaging at 7T. Neuroimage (2011) 0.99
Development of vascular risk factors over 15 years in relation to cognition: the Hoorn Study. J Am Geriatr Soc (2012) 0.98
Human prion diseases in the Netherlands (1998-2009): clinical, genetic and molecular aspects. PLoS One (2012) 0.98
Blood oxygenation level-dependent (BOLD) total and extravascular signal changes and ΔR2* in human visual cortex at 1.5, 3.0 and 7.0 T. NMR Biomed (2010) 0.98
DENSE and HARP: two views on the same technique of phase-based strain imaging. J Magn Reson Imaging (2006) 0.98